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Abstract
 
The transcription factors signal transducer and activator of transcription (STAT)1 and T-bet
control the differentiation of interferon (IFN)-
 
 
 
–producing T helper type (Th)1 cells. Here we
compare the role of T-bet and STAT1 in the initiation and regulation of experimental autoim-
mune encephalomyelitis (EAE), a disease initiated by Th1 cells. T-bet–deficient mice immu-
nized with myelin oligodendrocyte glycoprotein (MOG) were resistant to the development of
EAE. This protection was also observed when T-bet
 
 
 
/
 
  
 
mice were crossed to the MOG-specific
2D2 T cell receptor transgenic strain. In contrast, although T-bet is downstream of STAT1,
STAT1
 
 
 
/
 
  
 
mice were highly susceptible to EAE and developed more severe and accelerated
disease with atypical neuropathologic features. The function of T-bet was dominant as mice
deficient in both T-bet and STAT1 were also protected from EAE. CD4
 
  
 
CD25
 
  
 
regulatory T
cells from these two mice strains were fully competent and do not explain the difference in disease
susceptibility. However, enhanced EAE in STAT1
 
 
 
/
 
  
 
mice was associated with continued
generation of IFN-
 
 
 
–producing Th1 cells and up-regulation of selective chemokines responsible
for the increased recruitment of macrophages and neutrophils in the central nervous system.
Although the two transcription factors, STAT1 and T-bet, both induce IFN-
 
  
 
gene transcrip-
tion, our results demonstrate marked differences in their function in regulating pathogenic Th1
cell responses.
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Introduction
 
After encounter with antigen, naive CD4
 
  
 
T cells differen-
tiate into two different subsets, Th1 and Th2 cells, charac-
terized by distinct functions and cytokine profiles. Th1 cells
secrete IFN-
 
  
 
and mediate delayed-type hypersensitivity
responses. Th2 cells produce IL-4, IL-5, and IL-13, provide
help to B cells, and mediate protection against extracellular
pathogens (1). The differentiation of Th cells into Th1 or
Th2 cell subsets is controlled by a number of different factors
including the strength of TCR signal, the type of APCs,
and costimulatory molecule engagement. However, cytokines
and the transcription factors that lie downstream of them
play a dominant role in T cell differentiation. More specifi-
cally, the transcription factors T-bet, signal transducer and
activator of transcription (STAT)1, STAT4, and c-Rel are
essential for the development of Th1 cells while GATA3,
c-maf, JunB and STAT6 transcription factors are involved
in the differentiation of Th2 cells (2–4).
Experimental autoimmune encephalomyelitis (EAE) is a
T cell–mediated autoimmune disease of the central nervous
system (CNS), which serves as an animal model for multiple
sclerosis. EAE is typically characterized by lymphocytic and
mononuclear cell inflammatory infiltrates and demyelination
throughout the CNS (5, 6). There is strong evidence indi-
cating that Th1 cells are critical for the initiation of the dis-
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 CNS, central nervous system; EAE, ex-
perimental autoimmune encephalomyelitis; MIP, macrophage inflamma-
tory protein; MOG, myelin oligodendrocyte glycoprotein; STAT, signal
transducer and activator of transcription. 
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ease in immunocompetent animals. First, Th1 cell–type cy-
tokines are present in inflammatory EAE lesions in the
CNS during active disease and are down-regulated during
remission (7, 8). Furthermore, adoptive transfer experi-
ments show that encephalitogenic T cell clones possess a
typical Th1 cell phenotype (9, 10). Although the patho-
genic role of Th1 cells in EAE has been established, the
role of IFN-
 
 
 
, a key cytokine for Th1 cell development
and effector functions, is poorly understood. Previous data
indicate that IFN-
 
 
 
 
 
/
 
  
 
and IFN-
 
 
 
R
 
 
 
/
 
  
 
mice are more sus-
ceptible to EAE induction, suggesting a protective rather
than a disease-promoting role of IFN-
 
  
 
(11–14).
T-bet has been identified as a key transcription factor for
the development of Th1 cells and the induction of IFN-
 
 
 
production (3, 15). When ectopically expressed, T-bet in-
duces Th1 cell differentiation of Th precursor cells and of
polarized Th2 cells. In addition, mice deficient for T-bet
do not develop Th1 cells and fail to control Th1 cell–
dependent protozoan infection (16). IFN-
 
 
 
R signaling
with subsequent STAT1 phosphorylation is critical for the
induction of T-bet in T cells (17, 18). These results suggest
that the activation of naive T cells with specific antigen/
MHC ligands in the presence of IFN-
 
  
 
is sufficient for
T-bet expression. Lighvani et al. (17) suggest the presence
of a positive feedback loop between IFN-
 
  
 
STAT1 and
T-bet by which IFN-
 
  
 
STAT1–driven T-bet expression
induces further IFN-
 
  
 
production in Th1 cells.
We have evaluated the role of the STAT1–T-bet circuit in
EAE using mice selectively deficient in the transcription fac-
tors T-bet or STAT1. We show that T-bet–deficient mice
are resistant to EAE development and that STAT1-deficient
mice, like IFN-
 
 
 
 
 
/
 
  
 
mice, are highly susceptible to EAE.
CD4
 
  
 
T cells from STAT1
 
 
 
/
 
  
 
and T-bet
 
 
 
/
 
  
 
mice proliferate
equally well in response to the encephalitogenic peptide
myelin oligodendrocyte glycoprotein (MOG) 35-55, but
T-bet
 
 
 
/
 
  
 
mice completely fail to generate Th1 cells In contrast,
STAT1
 
 
 
/
 
  
 
mice retain a significant number of IFN-
 
 
 
–pro-
ducing Th1 cells. Mice lacking both T-bet and STAT1 are
also protected from the development of EAE. Taken to-
gether, these data provide strong evidence for a key role of
T-bet in regulating pathogenic T cells in EAE. In addition,
our results suggest that lack of IFN-
 
  
 
signaling in STAT1
 
 
 
/
 
 
 
mice results in the up-regulation of chemokines mediating
the recruitment of macrophages and neutrophils in the CNS.
 
Materials and Methods
 
Animals.
 
C57Bl/6 2D2 TCR transgenic mice are transgenic
for a TCR recognizing the CNS autoantigen MOG and have
been described previously (19). 129S6/SvEv STAT1
 
 
 
/
 
  
 
(20) and
129S6/SvEv control mice were obtained from Taconic. T-bet
 
 
 
/
 
 
 
mice have been backcrossed onto C57Bl/6 for at least five gener-
ations and have been described previously (16). 2D2 STAT1
 
 
 
/
 
 
 
mice have been backcrossed onto the C57Bl/6 strain for one
generation. T-bet
 
 
 
/
 
  
 
STAT1
 
 
 
/
 
  
 
mice were generated by inter-
crossing T-bet
 
 
 
/
 
  
 
STAT1
 
 
 
/
 
  
 
mice. To generate 2D2 TCR
transgenic mice selectively deficient in T-bet or STAT1 and
their littermate controls, T-bet
 
 
 
/
 
  
 
or STAT1
 
 
 
/
 
  
 
mice were
crossed with 2D2 TCR transgenic mice. 2D2
 
  
 
T-bet
 
 
 
/
 
  
 
or
2D2
 
  
 
STAT1
 
 
 
/
 
  
 
mice were then crossed with 2D2
 
  
 
T-bet
 
 
 
/
 
 
 
or 2D2
 
  
 
STAT1
 
 
 
/
 
  
 
mice, respectively, to generate 2D2
 
 
 
T-bet
 
 
 
/
 
 
 
, 2D2
 
  
 
T-bet
 
 
 
/
 
  
 
mice and 2D2
 
  
 
STAT1
 
 
 
/
 
 
 
, 2D2
 
 
 
STAT1
 
 
 
/
 
  
 
mice. Mice were housed in a specific pathogen-free,
viral antibody-free animal facility at the Harvard Institutes of
Medicine. All breeding and experiments were performed in ac-
cordance with the guidelines of the committee on Animals of
Harvard Medical School.
 
Antigens.
 
The peptide MOG 35-55 (MEVGWYRSPFSRV-
VHLYRNGK) was synthesized by D. Teplow (Center for Neu-
rologic Diseases, Boston, MA).
 
Purification of CD4
 
  
 
T Cells.
 
CD4
 
  
 
T cells were purified
from lymph nodes and spleens using anti-CD4 columns accord-
ing to the manufacturer’s instructions (Miltenyi Biotec).
 
Flow Cytometry and Cell Sorting.
 
After purification, CD4
 
  
 
T
cells were stained with anti-CD4 FITC and anti-CD25 PE anti-
bodies (PC61; BD Biosciences) and sorted using a FACS Van-
tage™ SE to obtain CD4
 
  
 
CD25
 
  
 
and CD4
 
  
 
CD25
 
  
 
T cells.
The purity of the cell suspensions was typically 
 
 
 
98%.
 
Proliferation Assays and Cytokine ELISA.
 
A sorted population
of CD4
 
  
 
CD25
 
  
 
lymphocytes (2.5 
 
  
 
10
 
4
 
/well), CD4
 
  
 
CD25
 
  
 
T
cells, and 
 
 
 
-irradiated APCs (4 
 
  
 
10
 
4
 
/well) were cultured for 3 d
in the presence of 1 
 
 
 
g/ml anti-CD3 (clone 2C11; Becton Dick-
inson). Cells were grown in RPMI supplemented with 10% FCS,
 
 
 
-mercaptoethanol, 
 
l
 
-glutamine, gentamicin sulfate, and penicil-
lin/streptomycin. For total CD4
 
  
 
T cell proliferation assay, 2.5 
 
 
 
10
 
5
 
/ml CD4
 
  
 
cells and 2.5 
 
  
 
10
 
6
 
/ml irradiated C57Bl/6 spleen
cells were cultured for 72 h in 96-well plates in the presence of
different concentrations of the MOG 35-55 peptide. Cells were
pulsed with 1 
 
 
 
Ci [
 
3
 
H]thymidine for the last 16 h of incubation.
Mean thymidine incorporation in triplicate wells was measured
using a 
 
  
 
counter (model LS 5000; Beckman Coulter). For analy-
sis of cytokine production, 5 
 
  
 
10
 
5 
 
CD4
 
  
 
T cells were cultured
in serum-free HL-1 medium (BioWhittaker) and stimulated with
5 
 
  
 
10
 
6 
 
syngeneic irradiated APCs and 100 
 
 g MOG 35-55 pep-
tide 1 wk after the initial stimulation. The concentrations of cy-
tokines IFN- , IL-4, IL-5, IL-10 (BD Biosciences), and TGF- 
(R&D Systems) were determined from these culture supernatants
by cytokine ELISA according to the manufacturer’s instructions
48 h after the stimulation.
Induction and Assessment of EAE. Two different protocols
were used to induce EAE. Transcription factor–deficient and
control mice were immunized with 100  g MOG 35-55 emulsi-
fied in CFA (CFA supplemented with 4 mg/ml of Mycobacterium
tuberculosis) and injected intravenously on days 0 and 2 with 150
ng pertussis toxin. 2D2 TCR transgenic mice received only an
injection of pertussis toxin. Clinical assessment of EAE was per-
formed daily and mice were scored for disease according to the
following criteria: 0, no disease; 1, decreased tail tone; 2, hind
limb weakness or partial paralysis; 3, complete hind limb paralysis;
4, front and hind limb paralysis; 5, moribund state. Transcription
factor–deficient and control mice crossed with the 2D2 TCR
transgenic mice were also observed daily for the development of
spontaneous EAE according to these criteria.
Histology. Animals were killed at the termination of the in-
duced disease or after signs of spontaneous EAE. Brains and spinal
cords were removed and fixed in 10% formalin. Paraffin-embed-
ded sections were stained with hematoxylin and eosin, Luxol fast
blue stains, and by Bielschowsky preparation for light microscopy
as described previously (19).
Analysis of Chemokines by Real-Time PCR. Groups of
STAT1 / , STAT1 / , T-bet / , and T-bet /  mice were immu-Bettelli et al. 81
nized with MOG 35-55 and injected with pertussis toxin as de-
scribed above. At the first signs of EAE, animals with EAE scores of
2–3 (for STAT1 /  and STAT1 /  mice) were anesthetized and
perfused with PBS. Brains from these animals were removed and
homogenized individually in TRIzol reagent (Invitrogen). RNA
was prepared according to the manufacturer’s instructions. After
treatment with DNase (Zymo Research), 2  g mRNA was reverse
transcribed (Bio-Rad Laboratories). Real-time PCR was performed
on each cDNA in duplicate using specific primers and probes.
Results
T-bet /  Mice Are Resistant to EAE Development. Be-
cause T-bet has been described as a major regulator of Th1
cell differentiation, we first evaluated its role in the devel-
opment of EAE by using mice selectively deficient in
T-bet. Groups of T-bet /  and T-bet /  mice were immu-
nized with the encephalitogenic MOG 35-55 peptide for
the development of EAE. The majority (86%) of T-bet / 
mice developed severe EAE with a high maximal score of
3.0 (Fig. 1 A, a, and Table I A). The disease was so severe
that 5 out of 21 (24%) of these animals died. By contrast,
most T-bet /  mice were resistant to the development of
EAE (Fig. 1 A, a, and Table I A). Only a small proportion
(26%) of T-bet–deficient mice showed mild signs of dis-
ease and none died as a consequence of EAE. Differences
in the clinical disease severity were reflected in differences
in numbers of CNS inflammatory foci in the two groups
(Table I A).
Figure 1. T-bet–deficient mice are resistant
to EAE induction, whereas STAT1 /  mice
develop fulminant EAE. (A) EAE development
in T-bet– and STAT1-deficient mice. Groups
of T-bet /  and T-bet /  mice and STAT1 / 
and 129 wild-type mice (6–7 mice per group)
were immunized with MOG 35-55 and in-
jected with pertussis toxin (a and c). T-bet / 
or T-bet /  2D2 MOG-specific TCR trans-
genic mice were injected with pertussis toxin
(b). Mice were observed daily for the develop-
ment of EAE. (B) Histology of 2D2 TCR trans-
genic mice with spontaneous EAE. (a) Posterior
spinal cord of a 2D2   T-bet /  mouse with
spontaneous EAE. There are small numbers of
typical mononuclear cell perivascular infiltrates
in leptomeninges and parenchyma (arrows).
There were similar infiltrates in 2D2  
STAT1 /  mice (not depicted). Magnification,
57. (b) Posterior spinal cord of 2D2   T-bet / 
mouse. There are no inflammatory lesions.
Magnification, 57. (c) Posterior spinal cord of
2D2   STAT1 /  mouse with severe clinical
disease. There is a large symmetric destructive
inflammatory lesion in the posterior columns.
Inset, higher power demonstrates confluent
parenchymal inflammatory cell infiltration, pre-
dominantly by neutrophils. Magnification, 57;
magnification of inset, 450. (d) Adjacent section
to (c) demonstrating absence of axons in lesion
center. Inset, higher power demonstrates neu-
trophils and complete loss of axons. Intact black
fibers are axons on the periphery of the lesion.
Magnification, 57; magnification of inset, 450.
(e) Brain stem of 2D2    STAT1 /  mouse
with atypical disease. A large subpial/sub-
ependymal inflammatory lesion adjacent to the
lateral foramen in the pons fills most of the
field. Myelinated fibers (blue) are preserved in
the lower left. *, cerebellum; magnification, 71.
(f) Higher power of brain stem lesion in (e)
with fibrin exudation from a vessel (arrow).
Neutrophils and foamy macrophages are the
predominant inflammatory cells. Magnification,
286. a–c, e, and f, Luxol fast blue/hematoxylin
and eosin stain; d, Bielschowsky silver impreg-
nation for axons.Role of T-bet and STAT1 in EAE 82
One possible mechanism for the low incidence of EAE
in T-bet /  mice could be a low frequency or a lack of ex-
pansion of myelin-specific T cells in these mice. To ad-
dress this issue, we crossed the T-bet /  mice with the
MOG-specific TCR transgenic 2D2 mice in which CD4 
T cells are specific for the encephalitogenic MOG 35-55
peptide. We previously reported that 2D2 TCR transgenic
mice develop EAE when injected with pertussis toxin
without immunization with MOG antigen (19). When in-
jected with pertussis toxin, the majority of 2D2   T-bet / 
wild-type mice developed severe EAE (Fig. 1 A, b). How-
ever, 2D2   T-bet /  mice were protected from the
development of EAE. We also previously reported that
2D2 transgenic mice develop spontaneous EAE with a low
frequency. Consistent with this observation, we found that
only 7% of 2D2   T-bet /  developed signs of spontane-
ous EAE (Table I B). However, we did not observe signs
of spontaneous EAE in 2D2   T-bet /  mice up to 3 mo
of age (Table I B). Therefore, despite harboring patho-
genic myelin-reactive T cells in their repertoire, 2D2  
T-bet /  mice were resistant to both induced and sponta-
neous EAE.
2D2   STAT1 /  Mice Are Susceptible to Induced EAE
and Develop Fulminant Spontaneous EAE. Recent studies
indicate that STAT1 is critical for the induction of T-bet
(17, 18). Therefore, we analyzed EAE susceptibility in
STAT1 /  and wild-type 129 control mice immunized
with MOG 35-55. The 129/SvEv mouse strain is relatively
resistant to the development of EAE with MOG 35-55 im-
munization and therefore develops disease with low inci-
dence and severity. In this study, 67% of wild-type 129/
SvEv mice immunized with MOG 35-55 developed EAE
but with a mean maximal score of 1.9 (Fig. 1 A, c, and Ta-
ble I B). In contrast to wild-type and T-bet /  mice, the
vast majority (95%) of STAT1 /  mice developed very se-
vere disease (mean clinical score of 3.9). Indeed, the disease
in this group was so fulminant that it resulted in the death
of 45% of the animals (Table I A).
To compare the development of EAE between T-bet / 
and STAT1 /  mice and to standardize the autopathogenic
repertoire between these two strains, we also generated
STAT1 /    2D2 TCR transgenic mice. 2 out of 40 (5%)
2D2   STAT1 /  mice developed spontaneous EAE (Ta-
ble I A). The 2D2   STAT1 /  mice that developed EAE
Table I. Induced and Spontaneous EAE in T-bet– and STAT1-deficient Mice
Clinical EAE Histological EAE
Incidence Mortality Mean maximal score Mean day of onset Mean number of inflammatory foci
A. Induced EAE
T-bet    18/21 (86%) 5/21 (24%) 3.0   0.4 16.6  0.7 54.5   16.4
T-bet    5/19 (26%)a 0/19 (0%)c 0.4   0.2e 19.8   2.7 11.6   2.8g
129 WT 12/18 (67%) 2/18 (11%) 1.9   0.4 20.2   1.3 55.2   10.7
STAT1    19/20 (95%)b 9/20 (45%)d 3.9   0.3f 19.7   1.1 105.4   20.5g
B. Spontaneous EAE
2D2   T-bet    0/52 (0%)h NAj NAj NDk 0   0
2D2   T-bet    3/41 (7%) 1.7   0.3 67.7   7.9 ND 8.0   0
2D2   STAT1    15/35 (43%)i 2.5   0.3 53.5   9.3 ND 99.8   18.2
2D2   STAT1    2/40 (5%) 1.0   0 73.5   2.0 ND 21.0   14.0
(A) Mice were immunized with 100  g MOG 35-55 and injected twice with 150 ng pertussi toxin. The results of three separate experiments are
shown.  Results for clinical EAE show the number of mice that developed EAE (incidence), the number of mice that died from EAE (mortality), the
mean clinical score   SE of each group, and the mean day of onset of EAE   SE among mice with EAE. Results for histological EAE are expressed
as mean number of meningeal and parenchymal inflammatory foci   SE in the brain and spinal cord of the group.
aP   0.005 when compared to T-bet /  or STAT1 /  group by Chitest.
bP   0.05 when compared to 129 WT, P   0.005 when compared to T-bet /  group by Chitest.
cP   0.05 when compared to T-bet /  or STAT1 /  group by Chitest.
dP   0.05 when compared to 129 WT and T-bet /  group by Chitest.
eP   0.005 when compared to T-bet /  and STAT1 /  group by t test.
fP   0.005 when compared to 129 WT and T-bet /  group by t test.
(B) Mice were observed  for a period of at least 3 mo for the development of clinical signs of EAE. The total number of mice observed in each
group was between 35 and 52 mice. Severity represents the mean maximal score of mice with EAE in each group. The mean age (in days) of spon-
taneous EAE onset is given for the mice that develop EAE in the group.
gP   0.005 between T-bet    and STAT1    group measured by t test.
hP   0.05 compared to 2D2   T-bet /  by Chitest and P   0.005 compared to 2D2   STAT1 / .
iP   0.005 compared to 2D2   STAT1 /  and 2D2   T-bet /  groups by Chitest.
jNot applicable.
kNot determined.Bettelli et al. 83
had a mild disease (mean clinical score of 1) at 73.5 d of age.
The incidence and severity of spontaneous EAE in 2D2  
T-bet /  mice and 2D2   STAT1 /  mice were similar.
However, in contrast to the 2D2   STAT1 /  mice, a large
proportion of 2D2    STAT /  mice (43%) developed
spontaneous EAE with very high severity (Table I B).
Histopathological examination of the brains and spinal
cords of 2D2   T-bet /  mice and 2D2   STAT1 / 
wild-type control mice showed small numbers of typical
mononuclear cell meningeal and parenchymal inflamma-
tory foci throughout the CNS (Fig. 1 B, a, Table I), as de-
scribed previously (19). In contrast, CNS tissues of 2D2  
T-bet /  mice that did not develop spontaneous EAE
showed no evidence of histologic disease (Fig. 1 B, b, Ta-
ble I). All but 1 of the 11 2D2   STAT1 /  mice exam-
ined had a distinct neuropathologic phenotype consisting
of large abscess-like confluent inflammatory/demyelinating
lesions localized in a restricted CNS anatomic distribution.
The lesions were found in the posterior columns of the spi-
nal cord in six mice (Fig. 1 B, c and d) and in the lateral as-
pect of the brain stem, often adjacent to trigeminal ganglia,
in eight mice (Fig. 1 B, e). Some of these lesions were par-
tially necrotic and showed extensive destruction of axons as
well as of myelin (Fig. 1 B, d). The inflammatory infiltrates
in these lesions were predominantly neutrophils, rather
than lymphocytes, and there were many foamy macro-
phages. In six mice, there was marked microvascular de-
struction and fibrin exudation from microvessels (Fig. 1 B,
f). Other portions of the CNS, i.e., cerebrum, basal ganglia,
and cerebellum, were normal. One 2D2    STAT1 / 
mouse had the typical perivascular mononuclear cell lesion
pattern usually observed in EAE. Thus, although most 2D2
TCR transgenic mice do not develop spontaneous EAE,
loss of STAT1 resulted in the development of spontaneous
EAE in a large proportion of the animals. This is in sharp
contrast to 2D2   T-bet /  mice, in which the majority of
TCR transgenic mice lacking T-bet did not develop EAE.
Because STAT1 induces T-bet, it is surprising that loss of
STAT1 enhanced EAE, whereas loss of T-bet prevented
mice from developing EAE.
CD4  CD25  T Cells from Both STAT1 /  and T-bet / 
Mice Are Able to Suppress T Cell Proliferation. CD4 
CD25  regulatory T cells can provide protection by sup-
pressing proliferation of effector CD4  CD25  T cells.
They have been shown to play a crucial role in maintaining
self-tolerance and in protecting against autoimmune disease
(21). A recent study shows that enhanced EAE in STAT1 / 
mice might be due to inefficient regulatory function of
CD4  CD25  cells. Therefore, we have analyzed the num-
ber of regulatory CD4  CD8  CD25  cells in the thymus of
STAT1 /  and STAT1 /  mice, but did not find any dif-
ference between the two mouse strains (unpublished data).
To investigate whether there was a difference in the regula-
tory function of CD4  CD25  T cells that could account
for the difference in EAE susceptibility between STAT1 / 
and T-bet /  mice, we separated CD4  CD25  and CD4 
CD25  T cells from STAT1-deficient, T-bet–deficient, or
their respective wild-type littermates, and tested the prolif-
erative response of the different CD4  CD25  effector pop-
ulations in the presence of CD4  CD25  regulatory cells
obtained from either STAT1 / , T-bet / , or wild-type
mice. None of the CD4  CD25  cell populations prolifer-
ated in response to anti-CD3 stimulation (Fig. 2). Prolifera-
tion of CD4  CD25  T cells from STAT1 /  or STAT1 / 
Figure 2. CD4  CD25  from both T-bet– and STAT1-deficient mice
can suppress the proliferation of effector CD4  T cells. CD4  CD25  and
CD4  CD25  T cells from STAT1 / , T-bet / , and respective wild-
type littermates were purified from the spleens and lymph nodes as described
in Materials and Methods. Proliferation of CD4  CD25  cells in the presence
of irradiated APCs, 1  g/ml anti-CD3 antibody, and different ratio of
CD4  CD25  T cells (from STAT1 knockout, bold hatched bars; STAT1
wild-type, hatched bars; T-bet knockout, closed bars; T-bet wild-type,
dotted bars) was determined by thymidine incorporation. These results are
representative of four independent experiments.
Figure 3. In absence of T-bet, STAT1 /  mice are protected from
EAE. Groups of T-bet /  (n   14), STAT1 /  (n   13), and STAT1 / 
T-bet /  (n   13) mice were immunized with MOG 35-55 and injected
with pertussis toxin. The development of EAE was followed over time.
The data represent two independent experiments.Role of T-bet and STAT1 in EAE 84
mice could be suppressed in a dose-dependent manner by
the addition of either STAT1 /  CD4  CD25  T cells or
STAT1 /  CD4  CD25  T cells (Fig. 2, A and B). In all
conditions, the regulatory activity of the STAT1 /  CD4 
CD25   T cells was not impaired. If anything, CD4 
CD25  from STAT1 /  mice showed an enhanced ability
to suppress wild-type CD4  CD25  effector cell prolifera-
tion (91 vs. 52% with CD4  CD25  from STAT1 / ).
Similarly, CD4  CD25  T cells from T-bet–deficient mice
were also more efficient at suppressing proliferation of
T-bet /  and T-bet /  effector CD4  CD25  T cells than
CD4  CD25  from T-bet wild-type mice (Fig. 2, C and
D). Because the function of CD4  CD25  regulatory cells
from STAT1 /  mice is unimpaired, these cells are unlikely
to account for the differences in EAE susceptibility between
STAT1 /  and T-bet /  mice.
In the Absence of T-bet, STAT1 /  Mice Are Resistant to
EAE Development. Although STAT1 seems to be impor-
tant for optimal T-bet induction in CD4  T cells, resid-
ual T-bet expression has been detected in CD4  T cells
of STAT1 /  mice with EAE (unpublished data) and of
STAT1 /  mice infected with Toxoplasma gondii (22). To
formally test the hypothesis that residual T-bet expression
plays a crucial role for the generation of pathogenic cells in
STAT1 /  mice, we generated mice deficient for both
T-bet and STAT1 and studied the development of EAE
in these animals. This also allowed us to determine
whether effects of STAT1 or T-bet are dominant. Groups
of STAT1 / , T-bet / , and (T-bet   STAT1) /  mice
were immunized with MOG 35-55 and the development
of EAE was scored over time. Consistent with our data,
STAT1 /  mice developed very severe disease, whereas
T-bet /  mice were more resistant to EAE induction (Fig. 3).
Mice deficient in both T-bet and STAT1 were also resis-
tant to EAE (Fig. 3), thereby recapitulating the phenotype
of the T-bet /  strain. These data indicate that the loss of
T-bet expression is dominant over STAT1 deficiency and
can prevent the development of EAE.
T-bet /  Mice, But Not STAT1 /  Mice, Fail to Develop
Th1 Cells. To investigate the basis for the difference in
EAE susceptibility between these two mouse strains, we
analyzed proliferative responses and cytokine production of
T cells derived from 2D2   T-bet / , 2D2   STAT1 / ,
and double deficient 2D2(T-bet   STAT1) /  mice and
compared them to those of their 2D2 wild-type littermates.
CD4  T cells were purified from the spleen and lymph
nodes and incubated with syngenic irradiated APCs and
MOG 35-55 peptide. 2D2   T-bet / , 2D2   STAT1 / ,
and 2D2(T-bet   STAT1) /  CD4  T cells proliferated
better in response to the encephalitogenic MOG 35-55
peptide than their respective 2D2   T-bet / , 2D2  
STAT1 / , 2D2(T-bet    STAT1) /   wild-type litter-
mates (Fig. 4 A). However, there was no difference in pro-
liferation between CD4  T cells from 2D2   T-bet /  and
2D2   STAT1 /  mice. Thus, resistance to EAE in the
2D2   T-bet /  mice did not result from a lack of activa-
tion or expansion of transgenic CD4  T cells specific for
the MOG peptide.
Next, we analyzed the cytokines produced by CD4  T
cells from these different strains in response to MOG 35-
55. Most significantly, we found residual IFN-  produc-
tion in CD4  T cells from STAT1 /  mice but not from
T-bet /  or (T-bet   STAT1) /  mice. We observed
reproducibly elevated levels of IL-10 in T-bet /  and
(T-bet   STAT1) /  CD4  cells. Thus, upon activation with
peptide, CD4  T cells from 2D2   T-bet / , 2D2  
STAT1 / , and 2D2   (T-bet, STAT1) /  mice (litter-
mate controls for the knockout mice) produced large
amounts of IFN-  (Fig. 4 B). However, little if any IFN- 
was detected in the cultures of CD4  T cells from either
2D2   T-bet /  mice or 2D2   (T-bet   STAT1) / 
mice. In contrast, CD4  T cells from 2D2   STAT1 / 
mice produced significant amounts of IFN- , as much as
10 ng/ml in response to MOG 35-55, although these lev-
els were lower than those produced by 2D2   STAT1 / 
mice (Fig. 4 B). There was no major difference in the
amount of TGF-    produced by the different mouse
strains. Levels of Th2 cell cytokines (IL-4, IL-5, and IL-
10) were reproducibly increased in all T-bet and double
deficient mice compared with their relative wild-type lit-
termates. Although the levels of IL-10 in the STAT1 / 
Figure 4. Proliferative response and cytokine production of T cells
from T-bet– and STAT1-deficient mice. CD4  T cells from naive
2D2   STAT1 / , 2D2   T-bet / , 2D2 (T-bet   STAT1) /  mice,
and relative wild-type littermates were stimulated in vitro with MOG
35-55 peptide and syngeneic APCs. Proliferation was measured 72 h later
by [3H]thymidine incorporation (A). The data are representative of at
least four independent experiments. IFN- , IL 10, IL-5, IL-4, and
TGF-  (B) produced in the culture supernatant was measured by ELISA
48 h after stimulation with peptide MOG 35-55 and APCs. (C) Ratio
of IL-10/IFN-  production in CD4  T cells from 2D2   T-bet / ,
2D2   T-bet / , 2D2   STAT1 / , 2D2   STAT1 / , 2D2 (T-bet  
STAT1) / , and 2D2 (T-bet   STAT1) / . The data are presented as
the average between three representative experiments   SE.Bettelli et al. 85
mice were more variable than in the T-bet–deficient or
(T-bet   STAT1) double deficient strain, the IL-10/IFN- 
ratio remained quite consistent and was substantially de-
creased in STAT1 /  mice but increased in T-bet /  mice
and (T-bet   STAT1) /  mice, correlating with the pro-
tection against EAE observed in these strains (Fig. 4 C).
Further, both the STAT1- and T-bet–deficient CD4  T
cells exhibit a hyperproliferative phenotype (Fig. 4 A),
which might further potentiate the skewed cytokine pro-
duction. However, this finding does not fully explain why
STAT1 /  mice have exacerbated disease compared with
STAT1 /  mice.
Up-regulation of Chemokines in CNS Tissues of STAT1 / 
Mice. Histological examination of brains and spinal cords
from STAT1 /  mice with EAE show atypical infiltration
dominated by neutrophils and macrophages rather than T
cells (Fig. 1 B). These observations suggested that there
was a differential recruitment of these cell populations in
the CNS in the absence of STAT1. Because chemokines
play an important role in cell migration, we analyzed their
expression in the CNS of mice with EAE. Groups of
STAT1 / , STAT1 / , and T-bet /  mice were immu-
nized with MOG 35-55 and pertussis toxin. At the first
attack of EAE, mice were perfused and brains were har-
vested. The expression of different chemokines was de-
termined by quantitative real-time RT-PCR (Fig. 5). The
expression of IP-10, MCP-1, and RANTES was de-
creased in STAT1 /  mice during EAE compared with
STAT1 /  mice. The decrease in these IFN- –inducible
chemokines is consistent with the absence of IFN-  sig-
naling in the STAT1 /  mice. In contrast, macrophage in-
flammatory protein (MIP)-1 , MIP-1 , and MIP-2 were
significantly increased in STAT1 /  mice compared with
STAT1 /  mice. In comparison, T-bet–deficient mice
with no EAE and hence no infiltrating leukocytes had de-
creased levels of these chemokines (unpublished data).
MIP-1  and MIP-1  are involved in the recruitment of
macrophages, whereas MIP-2 is thought to attract neutro-
phils to the site of inflammation (23–25). Therefore, the
enhanced production of MIP-1 , MIP-1 , and MIP-2 in
combination with a residual population of Th1 cells in
STAT1 /  mice may partly account for the massive and
distinct infiltration of macrophages and neutrophils into
the CNS of these mice and the consequent exacerbated
clinical disease.
Discussion
In this report, we have analyzed the roles played by two
transcription factors, T-bet and STAT1, in the induction
and regulation of EAE. Like IFN-  /  and IFN- R / 
mice, we show that STAT1 /  mice are highly susceptible
to EAE. Further, STAT1 /  mice crossed with MOG-spe-
cific TCR transgenic 2D2 mice developed fulminant spon-
taneous EAE. In contrast, T-bet /  mice did not develop
disease after immunization with MOG 35-55 peptide and
no MOG-specific TCR transgenic T-bet /  mice devel-
oped signs of spontaneous EAE. Therefore, the absence of
T-bet protected mice from EAE in all experiments. Fur-
thermore, although induction of T-bet is largely dependent
on STAT1, we found that T-bet played a dominant role in
controlling disease because mice lacking both T-bet and
STAT1 were resistant to EAE. CD4  CD25  T cells are
thymically derived regulatory T cell subtypes that mediate
peripheral tolerance and loss of this specific subtype of regu-
latory cells results in multiple organ autoimmunity (21). A
recent report proposed that increased EAE in STAT1 / 
mice results from a decrease in the number and activity of
CD4  CD25  T cells (26). In contrast to this report, our
experiments show that CD4   CD25   T cells from
STAT1 /  mice are quite efficient at suppressing the prolif-
eration of effector cells from either STAT1 /  or STAT1 / 
mice. In fact, in our hands, CD4  CD25  T cells from both
STAT1 /  and T-bet /  mice showed enhanced suppres-
sive activity compared with wild-type mice. Therefore, a
defect in the function of CD4  CD25  regulatory cells is
unlikely responsible for the difference in disease susceptibil-
ity between T-bet and STAT1-deficient mice.
The severe clinical EAE observed in the STAT1 /  mice
is similar to the exacerbated disease reported in IFN- –
and IFN- R–deficient mice. Previous reports showed that
CD4  T cells from IFN-  /  and STAT1 /  mice had
higher antigen-specific proliferative responses compared
with wild-type mice, suggesting that IFN-  may have anti-
proliferative effects and limit the expansion of CD4 
pathogenic T cells (14, 27, 28). Indeed, consistent with an
antiproliferative role of IFN- , we found that MOG-spe-
cific T cells from STAT1 / , T-bet / , and (T-bet  
STAT1) /   mice had higher proliferative responses to
MOG 35-55 compared with control wild-type mice.
However, this was unlikely to account for the difference in
disease susceptibility between T-bet /   and STAT1 / 
mice because T cells from T-bet /  and STAT1 /  mice
proliferated equally well.
However, there are several other possible explanations
for the observed differences in the EAE phenotypes. First,
STAT1 /  mice do have small amounts of residual T-bet
protein in Th cells that might be sufficient to induce IFN-
Figure 5. Chemokine expression in the brain of T-bet– and STAT1-
deficient mice during EAE. Groups of STAT1 /  and STAT1 /  mice
(five mice/group) were immunized with MOG 35-55 and pertussis toxin.
During the first attack of EAE, the brain from these mice was removed
and chemokine expression was determined by real-time PCR. The results
represent the mean relative mRNA expression (2-  CT   1,000) of a particular
chemokine within a group   SE between samples of this group.Role of T-bet and STAT1 in EAE 86
 –producing Th1 cells and EAE. In favor of this hypothe-
sis, we found significant amounts of T-bet in CD4  T cells
of 2D2 STAT1 /  mice with spontaneous EAE. A recent
report also showed that CD4  T cells from T. gondii–in-
fected STAT1 /  mice express T-bet (22). In addition, we
and others (26) have shown that CD4   T cells from
STAT1 /   mice can differentiate, albeit poorly, into
IFN- –producing Th1 cells. Residual T-bet expression in
STAT1 /  mice probably accounts for the generation of
pathogenic Th1 cells capable of initiating EAE in these
mice because (STAT1   T-bet) /  mice do not produce
any IFN-  and were also resistant to the development of
EAE. Analysis of Th2 cell cytokines produced by CD4  T
cells revealed that T-bet /  and (T-bet   STAT1) /  dou-
ble deficient mice displayed increased IL-10 production
compared with wild-type. Although amounts of IL-10
produced by STAT1 /  mice varied at different backcross
generations, the ratio between IL-10/IFN-   production
was always consistent and markedly different between these
different mice strains. The IL-10/IFN-   ratio was very
high in T-bet /  and (T-bet   STAT1) /  mice and much
lower in STAT1 /  mice. These results suggest that a bal-
ance between IFN- –producing Th1 cells and IL-10–pro-
ducing Tr1 cells may explain the resistant phenotype.
In addition, we have recent evidence that STAT1 is not
the only upstream regulator of T-bet in other cell types
such as NK cells (29). Thus, a pathogenic function for
T-bet in these cell types might exist in STAT1 /  mice.
Finally, T-bet transcripts are undetectable in macrophages
(30), a cell type in which STAT proteins have vital func-
tions (31). It is possible that the fulminant EAE observed in
the absence of IFN-  signaling arises from cellular mecha-
nisms distinct from those observed in typical EAE. Indeed,
2D2   STAT1 /  mice with spontaneous EAE had a dis-
tinct neuropathologic phenotype with a more restricted
distribution of large abscess-like confluent inflammatory/
demyelinating lesions composed predominantly of neutro-
phils and foamy macrophages, rather than lymphocytes.
During EAE, we found a substantial alteration in the pat-
tern of chemokines expressed in the brains of STAT1 / 
mice compared with wild-type mice. IFN- –inducible
chemokines such as IP-10 were down-regulated in the
brain of STAT1 /  mice, consistent with a lack of IFN- 
signaling in these mice. In contrast, we found an increase
in the level of MIP-1   and MIP-1   in the brain of
STAT1 /  mice. These chemokines are involved in the
recruitment of macrophages to inflamed sites and previous
data have shown that activated macrophages mediate most
of the tissue injury during EAE. Thus, it is possible that in-
creased infiltration of activated macrophages in the CNS is
responsible for the enhanced disease observed in STAT1 / 
mice. MIP-2 was also significantly up-regulated in the
brain of STAT1 /  mice. Similar up-regulation of MIP-2
has been reported in IFN-  /  mice with EAE (14). MIP-2
is specifically involved in the recruitment and chemotaxis
of neutrophils to the site of inflammation (23–25). Al-
though the up-regulation of MIP-1 and MIP-2 may in-
crease infiltration of foamy macrophages, MIP-2 might be
specifically responsible for the infiltration of neutrophils
and the generation of abscess-like lesions in the brains of
STAT1 /  mice.
Together, our observations show that loss of STAT1 in
STAT1-deficient mice does not prevent the generation of
autopathogenic Th1 cells, but loss of downstream transcrip-
tion factor T-bet completely eliminates the generation of
Th1 cells. Our data on STAT1 /  mice suggest that elimi-
nation of the IFN-  signaling pathway creates a dysequilib-
rium in the balance of IL-10/IFN-  and chemokines lead-
ing to differential recruitment of cell populations to target
tissues with resultant enhanced inflammation. However,
our data show that T-bet has a pivotal role in the genera-
tion of pathogenic Th1 cells and induction of EAE. There-
fore, T-bet rather than STAT1 may provide an important
target for manipulation of CNS autoimmune diseases.
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